Live Birth

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 31, 2026

Live birth is the complete expulsion or extraction from a woman of a fetus, irrespective of the duration of the pregnancy, which after such separation breathes or shows any other sign of life (heartbeat, umbilical cord pulsation, or definite movement of voluntary muscles), whether or not the umbilical cord has been cut or the placenta is attached. This definition is harmonized across the World Health Organization, ICD-10, ICD-11, MeSH, and the National Cancer Institute Thesaurus, making live birth a categorical outcome that does not depend on gestational age or duration of survival outside the womb.

Live birth is not the same as a healthy birth. The definition is a minimum threshold: any sign of life immediately after delivery satisfies it, regardless of gestational age, birth weight, congenital anomalies, NICU admission, or survival beyond the immediate postnatal period. Many live births are followed by neonatal complications, neonatal death, or lifelong morbidity. Outcome metrics that conflate live birth with healthy birth obscure the distinction between achieving delivery and achieving a healthy outcome for mother and baby.

Live birth is the primary outcome measure in fertility research because it captures the full chain of biological events required for a successful pregnancy: conception, implantation, embryonic and fetal development, and intact delivery. Lesser endpoints (positive pregnancy test, clinical pregnancy at ultrasound, ongoing pregnancy at twelve weeks) are intermediate markers that often diverge from live birth, particularly in patient populations with high risk of pregnancy loss.

In restorative reproductive medicine outcome studies, cumulative live birth rate over a defined treatment interval (commonly 24 months) is the preferred metric. It accommodates the multi-cycle nature of fertility treatment and avoids the inflation that affects per-cycle clinical pregnancy figures. Comparative cohorts of NaProTechnology care, including the Tham Canadian family-medicine cohort,¹ report cumulative live birth rates that contextualize the trajectory of patients treated with restorative approaches relative to assisted reproductive technology.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.